Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Legal, PR Efforts Ramp Up To Target J&J On Vaginal Mesh Device Issues

This article was originally published in The Gray Sheet

Executive Summary

The Corporate Action Network has launched a new website intended to shame the firm for practices tied to its withdrawn pelvic mesh implant devices, while requesting a Department of Justice investigation into the firm’s document-destruction activities and hatching plans to disrupt J&J’s annual shareholder meeting.

You may also be interested in...



J&J Risperdal Off-Label Settlement Includes Exec Pay Recoupment Provision

Janssen subsidiary pleads guilty as part of $2.2 billion deal that also requires audits of sales rep compensation.

J&J/Ethicon Begins Worldwide Withdrawal Of Vaginal Mesh Products

Firm is stopping sales of four of its vaginal mesh products in the face of over 1,000 product liability lawsuits and FDA requirements for post-market safety and efficacy studies.

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032867

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel